Drug recall · April 12, 2023
Rosuvastatin Tablets recall
Why: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.
- Lots / codes
a) Lot: F2022N, Exp. Date: 2/29/2024; b) Lot: F0322I, Exp. Date: 8/31/2023; Lot: J1322H, Exp. Date: 2/29/2024; Lot: K0222N, Exp. Date: 6/30/2024; Lot: L2322D and Lot: L2822J, Exp. Date:7/31/2025.
- Quantity
- a) 59 Bottles, b) 77 Bottles
- Company
- Preferred Pharmaceuticals, Inc., Anaheim, CA
- Distribution
- USA Nationwide
- Initiated
- March 23, 2023 · Voluntary: Firm initiated
- Classified
- April 6, 2023
- Reported
- April 12, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rosuvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.